Scailyte
Edit

Scailyte

http://www.scailyte.com/
Last activity: 08.01.2024
Categories: MedTechPlatformResearchSkinSoftwareAppBioTechDataDiagnosticsHealthTech
True precision medicine through single-cell science. Scailyte is an ETH Zürich spin-off with a best-in-class artificial intelligence platform for the discovery of complex disease patterns from single-cell data. Our solution provides unprecedented insight into diseases and enables ultra-sensitive diagnostics by uncovering human's hidden "single-cell"​ secrets. The performance and clinically-relevant application of Scailyte's platform ScaiVision have been demonstrated in numerous clinical projects that resulted in patent-pending biomarkers. Scailyte has a growing pipeline of clinical projects in immunology, oncology and women's health supported by top clinicians and access to high quality proprietary datasets. If you want to partner with us and save lives by enabling precision medicine, reach out to contact@scailyte.com More information about our company, technology & services you can find on our website - https://scailyte.com
Followers
210
Followers
3.67K
Mentions
43
Location: Switzerland, Basel-City, Basel
Employees: 11-50
Total raised: $16.99M
Founded date: 2017

Investors 5

Funding Rounds 3

DateSeriesAmountInvestors
08.01.2024Series A$8M-
02.10.2022Series A$6.2MVenture Ki...
19.12.2018Seed$2.79M-

Mentions in press and media 43

DateTitleDescriptionSource
08.01.2024Scailyte hits twin peaks: Extends Series A funding to USD 8 ...Last week, Scailyte, a Swiss innovator in single-cell and AI-guided biomarker discovery, agreed with...venturekic...
08.01.2024Scailyte hits twin peaks: Extends Series A funding to USD 8 ...Scailyte hits twin peaks: Extends Series A funding to USD 8 Million and transfers endometriosis diag...venturelab...
04.01.2024Hera Biotech acquires endometriosis diagnostic assets from S... Endometriosis is a highly prevalent and debilitating disease with severe health-economic impact th...startuptic...
05.12.2023Scailyte reaches USD 8 million in Series A Founded in 2017, Scailyte is on a mission to advance precision medicine with single-cell omics tec...startuptic...
12.05.2023Startups welcome seasoned industry leaders to their board Insphero’s CEO Jan Lichtenberg has joined Scailyte’s board. The ETH Zürich spin-off developed a di...startuptic...
01.10.2022Scailyte Closes CHF6M Series A FundingScailyte, a Basel, Switzerland-based med-tech company, raised CHF6M in Series A funding. The round ...finsmes.co...
22.09.2022Scailyte closes Series A funding with a CHF 6 million invest...Scailyte closes Series A funding with a CHF 6 million investment to develop strategic partnerships i...venturelab...
22.09.2022Scailyte closes Series A funding with a CHF 6 million invest...Scailyte’s priorities will be focused on advancing the endometriosis biomarker into the prototype va...venturekic...
22.09.2022Scailyte secures CHF 6 million to advance immuno-oncology Founded in 2017, Scailyte is on the mission to advance precision medicine with single-cell technol...startuptic...
17.06.2022Plug and play Basel welcomes its first cohort In November last year, Plug and Play, a globally renowned accelerator with over 60 locations, open...startuptic...
Show more

Reviews 0

Sign up to leave a review

Sign up Log In